Community-associated MRSA: Superbug at our doorstep

CMAJ. Canadian Medical Association Journal

Volumn 176, Issue 1, 2007, Pages 54-56

  Hawkes, Michael ^a   Barton, Michelle ^a   Conly, John ^b   Nicolle, Lindsay ^c   Barry, Clare ^d   Ford Jones, Elizabeth L ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; PENICILLIN G;

BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CANADA; COMMUNITY ASSESSMENT; DAY CARE; DISEASE SEVERITY; DISEASE TRANSMISSION; EPIDEMIC; FULMINATING PURPURA; HOUSEHOLD; HUMAN; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NECROTIZING FASCIITIS; NECROTIZING PNEUMONIA; NOTE; PATHOGENESIS; PET ANIMAL; PNEUMONIA; PRACTICE GUIDELINE; PYOMYOSITIS; SCREENING TEST; SEPSIS; SKIN INFECTION; SOFT TISSUE INFECTION; SPORT; UNITED STATES;

EID: 33846459015     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.061370     Document Type: Note

References (22)

1. Moellering RC Jr. The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. Ann Intern Med 2006;144:368-70.
2. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005;40:1785-01.
3. King MD, Humphrey BJ, Wang YF, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA300 clone as the predominant cause of skin and soft-tissue-infections. Ann Intern Med 2006;144:309-17.
4. Hinrichs IH. CA-MRSA: An old foe develops new fangs. Mo Med 2006;103:129-32.
5. Chambers HF. Community-associated MRSA-resistance and virulence converge. N Engl J Med 2005;352:1485-7.
6. Barton-Forbes M, Hawkes M, Moore D, et al. Guidelines tor the prevention and management of community associated methicillin resistant Staphyococcus aureus (CA-MRSA): a perspective for Canadian health care practitioners. Can J Infect Dis and Med Microbiol 2006; 17(Suppl C):1B-24B.
7. Taylor G, Kirkland T, Kowalewska-Grochowska K, et al. A multistrain cluster of methicillin-resistant Staphylococcus aureus based in a Native community. Can J Infect Dis 1990;1:121-6.
8. Kurbis, Wylie. Community-based cluster of methicillin-resistant Staphylococcus aureus in Manitoba. Can J Infect Dis 2001.;12:149-52.
9. Shahin R, Johnson IL, Jamieson F, et al. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Toronto Child Care Center Study Group. Arch Pediatr Adolesc Med 1999;153:864-8.
10. Wylie TL, Nowicki DL. Molecular epidemiology of community- and health care-associated methicillin-resistant Staphylococcus aureus in Manitoba, Canada. J Clin Microbiol 2005;43:2830-6.
11. McGeer A, Fleming CA, Green KA, et al. Changes in antimicrobial resistance in Ontario hospitals. Quality Management Program Laboratory Services. 2005. Available: www.qmpls.org/pub_resources/publications/qmpls_news/pdf/qmpls news089.pdf (accessed 2006 Nov 17).
12. Gilbert M, MacDonald J, Gregson D, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 2006;175:149-54.
13. Gilbert M, Siushansian J, Macdonald J., et al. An outbreak of the USA300 strain of community-acquired methicillin-resistant Staphylococcus aureus CMRSA infections in individuals with histories of drug use, homelessness or incarceration. Can J Infect Dis Med Microbiol 2005;16:108.
14. Conly J, Gilbert M, Zhang K, et al. Rapidly Progressive Fatal Necrotizing Pneumonitis secondary to Panton-Valentine Leukocidin PVL positive, SCCmec Type IVa Community-Acquired Methicillin-Resistant S aureus CAMRSA - A Harbinger of the Future. Can J Infect Dis Med Microbiol 2005;16:109.
15. Brophy J, Yau Y, Cox P, et al. Sentinel case of pediatric CA-MRSA in Canada. Paediatrics and Child Health. In press.
16. Janvier J, Elsayed S, Gregson D., et al. Necrotizing Pneumonia Secondary to CA-MRSA USA300 Strain Without Evidence of Antecedent Upper Viral Respiratory Infection. Can J Med Micro Infect Dis 2006;17:30.
17. Nicolle L. Community-acquired MRSA: a practitioner's guide. CMAJ 2006;175:145.
18. Allen UD. Public health implications of MRSA in Canada. CMAJ 2006;175:161.
19. Gorwitz RJ, Jernigan DB, Powers JH, et al. Strategies for clinical management of MRSA in the community: Summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. Available: www.cdc.gov/ncidod /dhqp/pdf)ar/CAMRSA_ExpMtgStrategies.pdf (accessed 2006 Nov 17).
20. Graham PL III, Lin SX, Larson EL. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med 2006;144:318-25.
21. Loeb M, Main C, Walker-Dilks C, et al. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. In: The Cochrane Library; Issue 4, 2003. Oxford: Update Software.
22. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001;7:178-82.